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Development of an effective vaccine against HIV has
proven to be particularly challenging to the scientific com-
munity in the absence of naturally occurring, protective
immune responses. Current vaccine candidates target
multiple internal and external gene product. Next genera-
tion vaccines will need to enhance the immunogenicity of
the envelope (Env), with the goal of improving the
breadth of the neutralizing antibody response while con-
currently stimulating cell-mediated immunity. However,
the envelope's genetic diversity and multiple mechanisms
for evading the human immune system have made it dif-
ficult to design successful candidates. Efforts at the Vac-
cine Research Center have centered on the use of genetic
and structural biological information to improve Env
immunogen design. The genetic approach has focused on
the conserved regions and conserved subdomains of vari-
able regions. To target such conserved domains, site-spe-
cific mutagenesis has been employed to generate and
analyze variant and chimeric Env proteins. Immunization
studies suggest that the V3 region plays a dominant role in
eliciting neutralization of viruses from different clades,
and some breadth of reactivity among V3 regions is
observed. The status of the structure-based immunogen
design effort and the status of the current human multic-
lade and multigene vaccine candidate will be reviewed.
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